Skip to content
Screener

Discontinued — last reported Q3 '24

Gross Profit at other companies

Labcorp Holdings logo
Labcorp HoldingsLH
$1.11B+6.3%
Rapid Micro Biosystems logo
Rapid Micro BiosystemsRPID
$371K-8.2%
Sotera Health logo
Sotera HealthSHC
$177.96M+6.8%
Ginkgo Bioworks logo
Ginkgo BioworksDNA
$18.44M-45.4%
Fortrea Holdings Inc. logo
Fortrea Holdings Inc.FTRE
$139.2M+4.3%
Revvity logo
RevvityRVTY
$387.66M+3.2%

Other financials

Income statement

See full
Revenue$1.0B-2.7%
Operating income$119.9M+19.7%
Net income-$1.5M-103%
EPS (diluted)-$0.03-103%

Balance sheet

See full
Cash & equivalents$240.6M+30.2%
Total debt$3.0B+8.1%
Total equity$2.8B-15.3%
Total assets$7.5B-0.4%

Cash flow

See full
Operating cash flow$179.7M-12.2%
CapEx$31.1M-11.9%
Free cash flow$148.6M-12.2%

Valuation

See full
Market cap$12.56B+70.1%
Enterprise value$15.36B+53.4%
P/S3.1×+1.3×

Profitability

See full
Gross margin84.7%
Operating margin13%-2.4pp
Net margin-6%
FCF margin9.3%-5.1pp

Returns & leverage

See full
Return on equity-7.7%
Debt / equity1.1×+0.2×
Current ratio1.3×0.0×

Where this comes from

Calculated from Charles River Laboratories’s reported figures.

The source filing: Charles River Laboratories’s 10-Q, filed November 5, 2025. Open the filing →

Filed
Nov 5, 2025
Fiscal quarter
Q3 FY2025
Calendar quarter
Q3 2025
Accession
0001100682-25-000043

FAQ

What is Charles River Laboratories's gross profit?
Charles River Laboratories (CRL) reported gross profit of $349.02M in Q3 2024.
How has Charles River Laboratories's gross profit changed year-over-year?
Charles River Laboratories's gross profit decreased by 3.5% year-over-year, from $361.84M to $349.02M.
What does gross profit mean?
Revenue minus cost of revenue — the profit available to cover operating expenses, representing the company's pricing power and production efficiency.

Ask your AI about Charles River Laboratories's gross profit.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude